Xbiome
Shenzhen
About Xbiome
Xbiome is the first AI pharmaceutical company in China that specializes in intestinal micro-ecology. It is based on intestinal micro-ecology and relies on AI technology to accurately and personally manage the gut health of 1.3 billion people. The company uses artificial intelligence to analyze patient and donor intestinal (gut) flora to more quickly develop effective pharmaceuticals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $124.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2021)
- Website: xbiome.cn
- Phone: 0755-86530994
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/xbiome-35215 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.